Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
Giovanni Landoni, Lorenzo Piemonti, Antonella d’Arminio Monforte, et al.
Infectious Diseases and Therapy (2022)
Open Access | Times Cited: 21

Showing 21 citing articles:

The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention
Seppe Cambier, Mieke Gouwy, Paul Proost
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 3, pp. 217-251
Open Access | Times Cited: 219
Neutrophil activation and neutrophil extracellular traps (NETs) in COVID‐19 ARDS and immunothrombosis
Maria Candida Cesta, Mara Zippoli, Carolina Marsiglia, et al.
European Journal of Immunology (2022) Vol. 53, Iss. 1
Open Access | Times Cited: 67
Neutrophil Extracellular Traps in Airway Diseases: Pathological Roles and Therapeutic Implications
Ara Jo, Dae Woo Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5034-5034
Open Access | Times Cited: 25
Prospects for targeting ACKR1 in cancer and other diseases
Kyler Crawford, Brian F. Volkman
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Therapeutic inhibition of CXCR1/2: where do we stand?
Sebastian Sitaru, Agnes Budke, Riccardo Bertini, et al.
Internal and Emergency Medicine (2023) Vol. 18, Iss. 6, pp. 1647-1664
Open Access | Times Cited: 24
Investigational pharmacological agents for the treatment of ARDS
Katyayini Aribindi, Michelle Lim, Satyan Lakshminrusimha, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 3, pp. 243-277
Closed Access | Times Cited: 9
Review of COVID-19 Therapeutics by Mechanism: From Discovery to Approval
Hee Sun Choi, A Young Choi, Jeffrey B. Kopp, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 14
Open Access | Times Cited: 6
Concomitant NAFLD Facilitates Liver Metastases and PD-1-Refractory by Recruiting MDSCs via CXCL5/CXCR2 in Colorectal Cancer
Yue Yang, Yunsong Chen, Zhaogang Liu, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 18, Iss. 2, pp. 101351-101351
Open Access | Times Cited: 5
Chemokine receptors in COVID-19 infection
Claudia Gutierrez-Chavez, Shalom Aperrigue-Lira, Brando Ortiz-Saavedra, et al.
International review of cell and molecular biology (2024), pp. 53-94
Closed Access | Times Cited: 4
Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19
Christopher M. Rice, Philip A. Lewis, Fernando M. Ponce-Garcia, et al.
Life Science Alliance (2022) Vol. 6, Iss. 2, pp. e202201658-e202201658
Open Access | Times Cited: 19
The effect of reparixin on survival in patients at high risk for in-hospital mortality: a meta-analysis of randomized trials
Giovanni Landoni, Alberto Zangrillo, Gioia Piersanti, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
NETosis Induced by Serum of Patients with COVID-19 is Reduced with Reparixin or Antibodies Against DEK and IL-8
İrfan Baki Kılıç, Açelya Yaşar, İrem Yalım Camcı, et al.
Turkish Journal of Immunology (2024), pp. 127-135
Open Access | Times Cited: 1
A narrative review of chemokine receptors CXCR1 and CXCR2 and their role in acute respiratory distress syndrome
Sophie Toya, Sofie Struyf, Luis Huerta, et al.
European Respiratory Review (2024) Vol. 33, Iss. 173, pp. 230172-230172
Open Access | Times Cited: 1
Casting a wide NET: an update on uncontrolled NETosis in response to COVID-19 infection
Erin B. Taylor
Clinical Science (2022) Vol. 136, Iss. 13, pp. 1047-1052
Open Access | Times Cited: 7
Respiratory viral infection and resolution of inflammation: Roles for specialized pro-resolving mediators
Luciana P. Tavares, Julie Nijmeh, Bruce D. Levy
Experimental Biology and Medicine (2023) Vol. 248, Iss. 19, pp. 1635-1644
Open Access | Times Cited: 3
Reparixin improves survival in critically ill and transplant patients: A meta‐analysis
Gioia Piersanti, Giovanni Landoni, Tommaso Scquizzato, et al.
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 10
Open Access | Times Cited: 2
Plasmon-enhanced circular dichroism spectroscopy of chiral drug solutions
Matteo Venturi, Raju Adhikary, Ambaresh Sahoo, et al.
The Journal of Chemical Physics (2023) Vol. 159, Iss. 15
Open Access | Times Cited: 2
Efficient synthesis of novel colchicine-magnolol hybrids and evaluation of their inhibitory activity on key proteases of 2019-nCoV replication and acute lung injury
Liu‐Yang Pu, Zhiyue Li, Feijuan Huang, et al.
Natural Product Research (2022) Vol. 38, Iss. 7, pp. 1238-1247
Closed Access | Times Cited: 4
ERS international congress 2022: Highlights from Assembly 2 on respiratory intensive care
Simon Valentin, Daniel López‐Padilla, Santi Nolasco, et al.
ERJ Open Research (2023) Vol. 9, Iss. 3, pp. 00532-2022
Open Access | Times Cited: 2
Letter to the Editor Regarding a Multicentric Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
Shun Ito, Masahiro Banno, Yuji Okazaki
Infectious Diseases and Therapy (2022) Vol. 12, Iss. 1, pp. 299-300
Open Access | Times Cited: 1
Response to “Letter to the Editor Regarding a Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia”
Flavio Mantelli
Infectious Diseases and Therapy (2022) Vol. 12, Iss. 1, pp. 301-302
Open Access
Page 1

Scroll to top